FDA-Drug2012-07-11Class III
Loxitane Capsules, Loxapine Succinate Capsules, 10mg base, 100 count bottle, Rx only, Watson Laboratories Inc., Corona, CA 92880 NDC # 52544-495-01
Watson Laboratories Inc
Hazard
Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.
Sold states
Nationwide.
Affected count
7,262 bottles
Manufactured in
311 Bonnie Cir, N/A, Corona, CA, United States
Products
Loxitane Capsules, Loxapine Succinate Capsules, 10mg base, 100 count bottle, Rx only, Watson Laboratories Inc., Corona, CA 92880 NDC # 52544-495-01
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1403-2012Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief